This case involves consolidated patent infringement actions brought by Eisai against Teva under 35 U.S.C. § 271(e)(2) after Teva filed ANDAs seeking FDA approval to market a generic version of Eisai's Aricept drug, which is covered by the '841 patent; Teva raised defenses of obviousness invalidity and later sought to add inequitable conduct based on Eisai's alleged failure to disclose co-pending patent applications to the PTO. The district court considered Teva's appeals from Magistrate Judge orders that struck portions of Teva's amended answers asserting inequitable conduct and denied related discovery requests. The court reversed the February Order striking the inequitable conduct allegations, vacated the appealed portions of the May Bench Order, and referred the matter back to the Magistrate Judge for further proceedings on discovery and the defense, while staying Eisai's summary judgment motion. The core reasoning centered on whether Teva's pleadings satisfied the particularity requirements of Rule 9(b) for fraud-based claims and whether the magistrate had applied an unduly strict standard in evaluating the allegations of materiality and intent to deceive.
The case involved breach of contract and tortious interference claims by Caribbean Telecommunications Ltd., a Guyana-incorporated company with its principal place of business in New Jersey, against Guyana Telephone & Telegraph Co., a Guyana corporation, and its parent Atlantic Tele-Network Inc., a Delaware corporation, arising from a telecommunications interconnection agreement in Guyana. The court considered sua sponte whether it had subject-matter jurisdiction under the diversity statute, 28 U.S.C. § 1332(a)(3), given the presence of alien corporations on both sides of the dispute. After analyzing the statute's text, history, and purpose, the court held that it lacked jurisdiction because the provision does not authorize suits where alien parties appear on opposing sides, even when domestic parties are also involved. The court further determined that the alien defendant was an indispensable party whose presence could not be severed to cure the defect and therefore dismissed the entire action with prejudice.
This case involves pretrial motions filed by defendant Russell Christie in a federal criminal prosecution alleging multiple counts of child pornography offenses under 18 U.S.C. § 2251, stemming from his alleged postings on a password-protected website facilitating the exchange of such material. The court denied Christie's motions to dismiss counts of the superseding indictment, to suppress evidence seized from his home pursuant to a search warrant, and for a Franks hearing, while reserving decision on suppression of his statements and denying various discovery and other independent requests. The core reasoning was that the warrant affidavit contained sufficiently detailed factual descriptions of the alleged images to establish probable cause, that the agents properly obtained and executed warrants for the correct address after an initial error, and that the indictment adequately alleged the elements of the offenses without violating applicable legal standards.
This case concerns Novartis's suit against Teva for alleged infringement of U.S. Patent No. 6,162,802, which covers methods and compositions for treating hypertension and other conditions using a combination of benazepril and amlodipine in physically separated forms within dosage units. Teva had filed an ANDA seeking FDA approval to market generic versions of Novartis's Lotrel drug before the patent expired, prompting Novartis to file suit under 35 U.S.C. § 271(e)(2). The court conducted a Markman hearing to construe disputed claim terms, including the requirement that the two active ingredients be kept physically separated due to their incompatibility, relying on the patent specification, prosecution history, and expert testimony. The opinion sets forth the court's constructions of the relevant claims without resolving infringement or validity.
This case involves pretrial motions in a federal criminal prosecution of David Delle Donna, Mayor of Guttenberg, New Jersey, and his wife Anna, who were charged in a five-count indictment with conspiracy to commit mail fraud, substantive mail fraud based on honest services, conspiracy to commit extortion under color of official right, and filing false federal tax returns. The charges stem from allegations that the defendants diverted campaign contributions for personal use, failed to properly report them under New Jersey law, and concealed income on tax forms. Defendants moved to dismiss the mail fraud counts for failure to state an offense, to sever the tax counts from the others, for a bill of particulars, and for early disclosure of Rule 404(b) evidence. The court denied all of defendants' motions, finding the indictment adequately alleged a cognizable honest services fraud theory rooted in fiduciary duties under state campaign finance statutes, that the counts were properly joined due to factual overlap, and that other requests were premature or unnecessary, while granting the government's reciprocal discovery motion.
This case involved a trademark dispute in which Vista India, operator of physical South Asian music retail stores, sued Raaga, LLC, operator of the raaga.com website offering online music streaming and downloads, alleging common-law trademark infringement, unfair competition, and related federal claims over use of the RAAGA mark. Vista sought a preliminary injunction to prevent Raaga from continuing to use the mark and domain name. The court denied the motion after applying the four-factor test for preliminary injunctive relief. The core reasoning was that Vista failed to demonstrate a likelihood of success on the merits, given that the mark appeared merely descriptive, Raaga had earlier use of the mark, and Vista had delayed in asserting its rights after learning of Raaga's operations.
